Chemoinformaics analysis of QUERCETIN-7-O-BETA-D-GLUCOPYRANOSIDE-BETA-L-RHAMNOPYRANOSIDE
| Molecular Weight | 610.521 | nRot | 6 |
| Heavy Atom Molecular Weight | 580.281 | nRig | 30 |
| Exact Molecular Weight | 610.153 | nRing | 5 |
| Solubility: LogS | -3.714 | nHRing | 3 |
| Solubility: LogP | -0.58 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 73 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 2 |
| nHetero | 16 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 16 | No. of Arom Bond | 17 |
| nHA | 16 | APOL | 77.9258 |
| nHD | 10 | BPOL | 39.6442 |
| QED | 0.14 |
| Synth | 4.784 |
| Natural Product Likeliness | 2.096 |
| NR-PPAR-gamma | 0.958 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.981 |
| HIA | 0.936 |
| CACO-2 | -6.382 |
| MDCK | 0.0000577 |
| BBB | 0.086 |
| PPB | 0.837209 |
| VDSS | 0.685 |
| FU | 0.118752 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.021 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.108 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.147 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.004 |
| CL | 1.515 |
| T12 | 0.52 |
| hERG | 0.011 |
| Ames | 0.832 |
| ROA | 0.049 |
| SkinSen | 0.034 |
| Carcinogencity | 0.323 |
| EI | 0.006 |
| Respiratory | 0.018 |
| NR-Aromatase | 0.943 |
| Antiviral | Yes |
| Prediction | 0.805032 |